Skip to content

Mirion Technologies MIR Medical Segment — D&A

Other segment segments

Nuclear & Safety
$24.3M+42.9%

Similar metrics at other companies

Becton, Dickinson and Company logo
BDXMedical — D&A
$348.25M+14.6%
Novanta logo
NOVTMedical Solutions — D&A
$9.58M+24.7%
Johnson & Johnson logo
JNJMedical Devices — D&A
$903M+8.0%
Becton, Dickinson and Company logo
BDXMedical Essentials — D&A
$147M+8.1%
Cardinal Health logo
CAHOther Segments — D&A
$26M-16.1%
PACS Group logo
PACSReportable Segment — D&A
$18.08M+42.3%

Other financials

Income statement

See full
Revenue$257.6M+27.5%
Gross profit$119.1M+23.9%
Operating income$3.7M-57.5%
Net income-$3.4M-1,233%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$400.8M+115%
Total debt$478.3M-33.5%
Total equity$1.8B+22.2%
Total assets$3.5B+34.7%

Cash flow

See full
Operating cash flow$18.9M-46.9%
CapEx$9.5M+11.8%
Free cash flow$9.4M-65.3%

Valuation

See full
Market cap$4.55B+35.0%
Enterprise value$4.63B+18.5%
P/E181.4×
P/S4.6×+0.8×

Profitability

See full
Gross margin47.1%+0.1pp
Operating margin4.7%+0.3pp
Net margin2.6%
FCF margin9.1%-0.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.2×
Current ratio3.2×+1.0×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirion Technologies's medical segment — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirion Technologies's medical segment — D&A?
Mirion Technologies (MIR) reported medical segment — D&A of $16.2M in Q1 2026.
How has Mirion Technologies's medical segment — D&A changed year-over-year?
Mirion Technologies's medical segment — D&A decreased by 1.2% year-over-year, from $16.4M to $16.2M.
What is the long-term trend for Mirion Technologies's medical segment — D&A?
Over 3 years (2022 to 2025), Mirion Technologies's medical segment — D&A has grown at a -7.4% compound annual growth rate (CAGR), from $82.4M to $65.5M.
What does medical segment — D&A mean?
Represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the Medical segment. This non-cash expense reflects the wear and tear of equipment and the consumption of acquired intangible assets like patents or customer relationships. It is a critical component for understanding the segment's asset intensity and for reconciling operating income to cash flow.